Xuehao H. Wang
No. 300, Guangzhou Road
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Radioprotectant-loaded visualizable cationic radioactive microspheres: Reduced hepatic tissue damage and intra/postoperative imaging during TARE.
Journal: Materials today. Bio
Published: November 21, 2025
Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma.
Journal: Gut
Published: October 20, 2025
Radiogenomics predicts immune microenvironment heterogeneity and response to combination immunotherapy in hepatocellular carcinoma.
Journal: Journal of translational medicine
Published: March 01, 2025
Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances.
Journal: Signal transduction and targeted therapy
Published: December 19, 2024
Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target.
Journal: Clinical and molecular hepatology
Published: October 09, 2024
Correction: c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses.
Journal: Signal transduction and targeted therapy
Published: March 23, 2024
Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: October 31, 2023
Diagnosis and therapy of tacrolimus toxicity in a liver transplant recipient during COVID-19 treatment.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: April 08, 2023
Retraction Note: miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
Journal: Cell death & disease
Published: March 29, 2023
Last Updated: 09/26/2026